Physician profile
Aref Karbasi
NPI 1710208046
$1,152.46
in general payments reported to CMS, 2019-2025
18 companies · $83.65 in 2025
The $83.65 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $70.92 · 2021: $258 · 2022: $340 · 2023: $147 · 2024: $95.97 · 2025: $83.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $236.57 | 2019-2021 | |
| Astellas Pharma US INC | $188.34 | 2022 | |
| Cardiovascular Systems INC. | $133.27 | 2019 | |
| Exact Sciences Corporation | $76.48 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $69.23 | 2021-2025 | |
| Glaxosmithkline, LLC. | $60.98 | 2022 | |
| Nestle Healthcare Nutrition INC. | $58.27 | 2021-2023 | |
| Lilly USA, LLC | $50.31 | 2022 | |
| Sumitomo Pharma America, INC. | $47.23 | 2023 | Gemtesa |
| Idorsia Pharmaceuticals US INC | $42.13 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $42.03 | 2021 | |
| Aimmune Therapeutics, INC. | $30.50 | 2024-2025 | Zenpep |
| Astrazeneca Pharmaceuticals Lp | $28.46 | 2023 | Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.04 | 2024 | Xifaxan |
| Pfizer INC. | $22.66 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.67 | 2022 | |
| Shield Therapeutics INC | $15.13 | 2025 | |
| Novo Nordisk INC | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aref Karbasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.